Yes, doctors can legally accept and exercise equity in digital health startups they advise. But the regulatory machinery around that "yes" is unforgiving, and most physicians I talk to dramatically underestimate how much legal architecture sits between them and a clean equity grant.
Here's what you need to know before you sign anything.
This content is for educational purposes only and does not constitute financial advice, legal advice, or tax advice. Figures vary based on individual circumstances, and you should consult a qualified professional before acting on anything described below.
Before committing your time and expertise, it is vital to understand equity negotiations what seasoned physician founders never accept to protect your financial interests.
The Short Answer: Yes, But With Strict Compliance
Doctors can hold equity in digital health startups they advise. Federal and state regulators permit it. What regulators don't permit is using that equity as a veiled kickback for patient referrals or for influencing the purchase of health services reimbursable by federal healthcare programs.
The legal foundation rests on two pillars: Stark Law (the physician self-referral statute) and the federal Anti-Kickback Statute (AKS). Both are criminal statutes. Both carry potential exclusion from Medicare and Medicaid. Both are interpreted broadly. And both treat physician equity arrangements with extreme suspicion when the physician has the power to generate revenue for the company.
Fair market value (FMV) is the operative concept. Whatever equity and cash compensation you receive must reflect the actual market rate for the advisory services you deliver, full stop. If the equity grant is wildly disproportionate to the time, deliverables, and expertise you're providing, you've just created a compliance exposure that the HHS Office of Inspector General (OIG) can prosecute.
I'll be blunt: most physician advisory agreements I see in the wild are sloppy on this point. Founders want to lock down physician advisors and often throw equity at the relationship without proper documentation. Physicians, flattered by the attention, sign whatever's put in front of them. That's how people end up in OIG investigations.
The structure that works: a written advisory agreement with specific deliverables, hourly rates comparable to healthcare consulting benchmarks, an independent valuation of the equity component, and zero coupling between your compensation and any patient referrals, software usage, or device prescriptions.
Navigating Federal Stark Law and Anti-Kickback Statute (AKS)
Here's the regulatory reality most physician advisors don't internalize until it's too late.
The Anti-Kickback Statute prohibits paying or receiving anything of value to induce referrals or business reimbursable by federal healthcare programs. Equity is "anything of value." If you can steer patients to use a product, service, or platform owned by a startup that compensated you with stock, you're looking at potential AKS exposure. Same logic applies if you prescribe devices, order tests, or recommend software that the startup sells.
Stark Law adds another layer: it prohibits physicians from referring Medicare or Medicaid patients to entities with which they have a financial relationship. Equity creates a financial relationship. The arrangement triggers Stark analysis even if you never actually refer anyone.
Safe harbors exist, but they're narrow.
The personal services safe harbor (42 CFR § 1001.952(d)) covers bona fide advisory agreements when specific requirements are met:
- Written agreement signed by both parties
- Services actually performed
- Aggregate compensation set in advance, consistent with FMV, and not determined in a manner that takes into account the volume or value of any referrals or business generated between the parties
- Services don't involve counseling or promotion of a business arrangement that violates federal or state law
- Services don't exceed those reasonably necessary
The investment interest safe harbor (42 CFR § 1001.952(a)) protects passive investment in venture capital-style funds, but it generally won't protect direct equity stakes in a single startup where you serve as an advisor.
The OIG has repeatedly warned about physician equity in digital health companies. Their 2020 special fraud alert on speaker programs and the ongoing scrutiny of telehealth arrangements show exactly where enforcement priorities sit. If you're advising a company that bills Medicare and you hold equity, you're in the enforcement spotlight.
The bottom line: if you refer patients to the startup, use their product in clinical care, or could influence purchasing decisions at your institution, your equity arrangement faces aggressive regulatory scrutiny. If you're a pure advisor with no referral path, you have more wiggle room, but documentation still has to be airtight.
Structuring the Advisory Agreement and Equity Vesting
The advisory agreement is your first line of defense in any future compliance audit. Generic "physician advisor" contracts with vague deliverables are an enforcement magnet.
Build the agreement around specific, measurable deliverables. Not "advise on product strategy," but "deliver quarterly market access reports, attend four advisory board meetings annually, provide feedback on clinical workflow integration within 30 days of each product release." Every hour you bill, every deliverable you produce, creates documentation proving actual services rendered.
Vesting schedules matter. Time-based vesting (typically over two to four years) shows ongoing commitment. Milestone-based vesting tied to specific deliverables (regulatory submission, product launch, clinical study completion) shows that equity is compensation for work, not a referral incentive.
The vesting structure should match the lifecycle of your actual involvement. A four-year vest with a one-year cliff is industry standard. Monthly vesting after the cliff keeps you compliant and keeps your incentive aligned with the company's long-term success.
Independent valuation is non-negotiable. The IRS Section 409A valuation establishes the strike price for your options. Without a qualified 409A appraisal from an independent firm, your equity grant has no defensible FMV. If regulators question whether your compensation was reasonable, that 409A report is your evidence.
Here's what equity allocation actually looks like in practice:
For early-stage digital health startups, advisory equity typically ranges from 0.25% to 1.0%. Series A advisors generally receive 0.1% to 0.5%. Late-stage advisors see 0.05% to 0.2%. These ranges reflect declining influence-per-dollar as the company matures and the cap table fills with institutional investors.
If a founder offers you more than these ranges without commensurate deliverables, ask hard questions about why. If they're offering less and demanding significant time commitment, that's also a yellow flag.
Exercise mechanics carry tax consequences. Exercising non-qualified stock options triggers ordinary income tax on the spread between strike price and fair market value at exercise. Incentive stock options (ISOs) have different rules and potential alternative minimum tax exposure. Don't exercise without understanding the tax picture first.
Institutional Conflicts of Interest and Employer Policies
Here's where most physicians get blindsided.
Your hospital employer or academic medical center didn't write your employment contract to be friendly to side ventures. Most large systems and academic centers have aggressive conflict of interest policies that require disclosure, review, and often formal approval before you can accept external compensation or equity.
I've watched employed physicians get suspended or terminated for taking startup advisory roles without disclosure. The termination was contractually clean because the employer's conflict of interest policy gave them the authority. The physician's equity was worthless because they couldn't continue advising, and the vesting clock kept ticking.
Before you sign anything:
- Pull your employment contract and read the moonlighting, outside employment, and intellectual property clauses. Understand what you're contractually obligated to disclose and approve.
- Contact your institution's conflict of interest office. Most large health systems have a formal review process for external business activities. Some require full committee review. Others just require disclosure forms.
- Identify whether your advisory work could be construed as competing with your employer. If you're advising a digital health company in the same therapeutic area your hospital's service line covers, expect pushback.
- Understand IP assignment clauses. Some employment contracts assign all "related" intellectual property to the employer. If your advisory work involves inventions or product ideas, your employer might claim ownership.
Academic medical centers are particularly aggressive. Stanford, UCSF, Penn, and most major academic systems have entire offices dedicated to industry relationships. The policy frameworks typically require disclosure of any equity above de minimis thresholds ($5,000-$10,000 is common), formal conflict review, and sometimes public reporting.
Private practice physicians have more flexibility but still face credentialing and payer contract implications. Medicare Advantage plans, ACO participation, and value-based care contracts increasingly ask about financial relationships with healthcare vendors.
The physicians who navigate this successfully treat institutional approval as a prerequisite, not an afterthought. They disclose early, document the request, get written approval, and maintain ongoing reporting. The physicians who get burned treat disclosure as optional and discover too late that their employer sees startup equity as a threat.
Key Takeaways
Here's what you need to internalize before taking any digital health startup equity:
- You can legally hold equity in startups you advise, but compliance with Stark Law and the Anti-Kickback Statute is non-negotiable. Both are criminal statutes with severe penalties.
- Advisory compensation and equity must reflect verifiable Fair Market Value for actual services rendered. Get an independent 409A valuation. Document your deliverables. Track your hours.
- Never tie advisory equity or compensation to patient referrals, clinical use, or purchasing decisions. Even indirect ties create prosecution risk.
- Always clear equity arrangements through your primary institutional employer's conflict of interest office. Written approval protects you. Assumed permission doesn't.
- The structure matters as much as the equity itself. Vesting schedules, FMV documentation, and compliance with safe harbor requirements determine whether your advisory role survives an audit.
